Stereotaxis Inc

Research Stereotaxis Inc (STXS) on Bullrun: market cap USD 138.09M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 138.09M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 32.38M-USD 21.64M-USD 13.78M52.7%-0.25USD 13.42MUSD 5.44MUSD 13.48M
FY2024USD 26.92M-USD 24.05M-USD 8.53M54.2%-0.3USD 12.22MUSD 6.01MUSD 6.08M
FY2023USD 26.77M-USD 20.71M-USD 9.51M55.5%-0.27USD 19.82MUSD 5.49MUSD 16.34M
FY2022USD 28.15M-USD 18.29M-USD 10.79M65.6%-0.26USD 8.59MUSD 5.99MUSD 26.35M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 138.09Mn/an/an/a
20252025-12-31USD 219.27Mn/an/an/a
20242024-12-31USD 194.54Mn/an/an/a
20232023-12-29USD 141.55Mn/an/an/a
20222022-12-30USD 154.93Mn/an/an/a
20212021-12-31USD 462.61Mn/an/an/a

About Stereotaxis Inc

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Stereotaxis Inc's market cap?

Stereotaxis Inc's market capitalization is USD 138.09M.

What does Stereotaxis Inc do?

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.